---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294097189.md"
description: "Healthcare stocks showed significant intraday volatility on Tuesday. Gainers included OPKO Health (+34.7%), ProMIS Neurosciences (+25.74%), and Kiniksa Pharmaceuticals (+24.43%), with several citing Q2 earnings reports. Conversely, major losers featured Enlivex (-43.7%), Bristol-Myers Squibb Celegne CVRs (-31.11%), and Replimune Group (-30.6%). The session highlighted sharp price movements driven by earnings releases across the healthcare sector."
datetime: "2026-07-28T17:06:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294097189.md)
  - [en](https://longbridge.com/en/news/294097189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294097189.md)
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **OPKO Health** (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.
-   **ProMIS Neurosciences** (NASDAQ:PMN) stock increased by 25.74% to $14.74. The company's market cap stands at $105.1 million.
-   **Kiniksa Pharmaceuticals** (NASDAQ:KNSA) stock increased by 24.43% to $79.06. The company's market cap stands at $4.8 billion. As per the news, the Q2 earnings report came out today.
-   **CytoMed Therapeutics** (NASDAQ:GDTC) shares increased by 17.8% to $1.06. The market value of their outstanding shares is at $10.6 million.
-   **Repligen** (NASDAQ:RGEN) stock increased by 15.64% to $151.56. The market value of their outstanding shares is at $7.3 billion. As per the press release, Q2 earnings came out today.
-   **VSee Health** (NASDAQ:VSEE) stock moved upwards by 15.0% to $0.09. The company's market cap stands at $3.7 million.

### Losers

-   **Enlivex** (NASDAQ:ENLV) shares declined by 43.7% to $2.4 during Tuesday's regular session. The market value of their outstanding shares is at $71.7 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock decreased by 31.11% to $0.08.
-   **Replimune Group** (NASDAQ:REPL) stock decreased by 30.6% to $5.99. The market value of their outstanding shares is at $724.4 million.
-   **Nautilus Biotechnology** (NASDAQ:NAUT) stock fell 28.62% to $1.19. The company's market cap stands at $210.9 million. The company's, Q2 earnings came out today.
-   **Advanced Biomed** (NASDAQ:ADVB) stock declined by 28.1% to $10.32. The company's market cap stands at $23.4 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares fell 25.51% to $0.05. The market value of their outstanding shares is at $2.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [KNSA.US](https://longbridge.com/en/quote/KNSA.US.md)
- [ENLV.US](https://longbridge.com/en/quote/ENLV.US.md)
- [OPK.US](https://longbridge.com/en/quote/OPK.US.md)
- [PMN.US](https://longbridge.com/en/quote/PMN.US.md)
- [GDTC.US](https://longbridge.com/en/quote/GDTC.US.md)
- [RGEN.US](https://longbridge.com/en/quote/RGEN.US.md)
- [VSEE.US](https://longbridge.com/en/quote/VSEE.US.md)
- [NAUT.US](https://longbridge.com/en/quote/NAUT.US.md)
- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [VSEEW.US](https://longbridge.com/en/quote/VSEEW.US.md)

## Related News & Research

- [Bristol-Myers Squibb Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/294214143.md)
- [Earnings snapshot: BMY boosts outlook; Eliquis demand growth tempered by generic competition in legacy portfolio](https://longbridge.com/en/news/294356448.md)
- [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)
- [Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields](https://longbridge.com/en/news/294061584.md)
- [OPKO Health Q2 loss narrows on higher IP revenue, lower costs](https://longbridge.com/en/news/293970820.md)